Personnel

Hana Biosciences Appoints Lyn Wiesinger to Board of Directors

Published in Cancer Weekly, March 13th, 2007

Hana Biosciences (NASDAQ:HNAB), a biopharmaceutical company focused on advancing cancer care, announced the appointment of Lyn Wiesinger to its Board of Directors. Her career has encompassed leadership roles at Pfizer, Rhone-Poulenc Rorer, Bristol-Myers Squibb and Vicuron Pharmaceuticals.

"We are extremely pleased to have Ms. Wiesinger, a seasoned pharmaceutical and biotech industry veteran, join our Board of Directors," stated Mark Ahn, Ph.D., President and Chief Executive Officer. "With more than 20 years of pharmaceutical operating experience, Ms Wiesinger's wealth of industry management, development and commercial expertise make her an excellent addition to Hana's...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Source: Cancer Weekly (2007-03-13)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry